HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

PrEP | Image credit: alimyakubov - stock.adobe.com
Higher Levels of PrEP Use Associated With Reduction in HIV Diagnoses

June 30th 2025

Making pre-exposure prophylaxis (PrEP) more accessible can help to decrease the incidence of HIV in the US.

PrEP | Image credit: Bowonpat - stock.adobe.com
Researchers Estimate PrEP Needed in the US Across Multiple Subgroups

June 24th 2025

Colleen Kelley, MD, MPH
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH

June 20th 2025

Image credit: Yale School of Medicine
Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

June 19th 2025

FDA Approved
Twice-Yearly Lenacapavir Approval Marks Major Milestone in Prevention of HIV

June 18th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
July 2nd 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases
July 2nd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 2nd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Phase 1 Study Demonstrates Safety of Pembrolizumab in Patients With HIV and Advanced Cancer
June 18th 2019

Phase 1 Study Demonstrates Safety of Pembrolizumab in Patients With HIV and Advanced Cancer

Jaime Rosenberg
The researchers concluded that pembrolizumab is appropriate for FDA-approved indications and clinical trials among patients with HIV.
Dr Stella Safo Discusses the Impact of Value-Based Care on People Living With HIV
June 14th 2019

Dr Stella Safo Discusses the Impact of Value-Based Care on People Living With HIV

HIV care delivery has always had an ethos in it of really being based on a team-based approach, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
This Week in Managed Care: June 14, 2019
June 14th 2019

This Week in Managed Care: June 14, 2019

This week, the top managed care news included the Community Oncology Alliance submitting an alternative to the Oncology Care Model; more study results demonstrating diabetes drugs can prevent renal failure; US task force recommending pre-exposure prophylaxis for HIV prevention.
USPSTF Issues Recommendation Statements on PrEP, Screening for HIV
June 11th 2019

USPSTF Issues Recommendation Statements on PrEP, Screening for HIV

Jaime Rosenberg
The United States Preventive Services Task Force (USPSTF) has issued 2 recommendation statements including 3 grade A recommendations for the use of pre-exposure prophylaxis (PrEP) for HIV prevention and HIV screening in adults, adolescents, and pregnant women.
Ending the HIV Epidemic: Why the US Is in the Position to Do So
June 5th 2019

Ending the HIV Epidemic: Why the US Is in the Position to Do So

Jaime Rosenberg
During the Center for Strategic & International Studies’ event “HIV/AIDS in the Unites States: The Road to 2030,” Anthony S. Fauci, MD, director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, and Robert Redfield, MD, director, CDC, joined to explain why the country is ready and able to end the epidemic from both a policy and clinical perspective.
Site Logo
June 4th 2019

Enhanced Care Coordination Improves HIV Viral Load Suppression Rates

Ross G. Hewitt, MD Debra Williams, EdD Richard Adule Ira Feldman, MPS Moe Alsumidaie, MBA, MSF
Enhanced care coordination in New York City that leveraged surveillance data with a health plan’s Medicaid managed care roster improved its HIV viral load suppression rate.
People Living With HIV Face Higher Risk of CVD, Barriers to Accessing Care
June 3rd 2019

People Living With HIV Face Higher Risk of CVD, Barriers to Accessing Care

Jaime Rosenberg
People living with HIV are generally at 1.5- to 2-fold higher risk for cardiovascular diseases (CVDs), including heart attacks, strokes, and heart failure, and they often face barriers to accessing care.
Dr Stella Safo Emphasizes the Importance of PrEP for Ending the HIV Epidemic
June 1st 2019

Dr Stella Safo Emphasizes the Importance of PrEP for Ending the HIV Epidemic

Pre-exposure prophylaxis (PrEP) is one of the best interventions we have for preventing and stopping HIV transmission, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Nearly 1 in 5 People Living With HIV Have Suboptimal Geographic Access to HIV Care
May 30th 2019

Nearly 1 in 5 People Living With HIV Have Suboptimal Geographic Access to HIV Care

Jaime Rosenberg
Nearly 10% of people living with HIV have to travel more than an hour to access HIV care, and those living in rural counties have drive times more than double that of those in urban counties.
Dr Stella Safo Outlines Challenges Associated With Aging HIV Populations
May 24th 2019

Dr Stella Safo Outlines Challenges Associated With Aging HIV Populations

From the health system perspective, there needs to be improvement in treating HIV as a comprehensive disease that now goes into aging, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Suspension of a Rural Syringe Service Program Increased Risks of HIV and HCV Acquisition
May 24th 2019

Suspension of a Rural Syringe Service Program Increased Risks of HIV and HCV Acquisition

Wallace Stephens
After a rural syringe service program was indefinitely suspended, individuals who inject drugs had a greater risk of contracting HIV and hepatitus C virus.
Study Examines Effects of Alcohol, HIV, HCV on Immune System Activation
May 18th 2019

Study Examines Effects of Alcohol, HIV, HCV on Immune System Activation

Wallace Stephens
A study examined how biomarkers of microbial translocation and innate immune activation were affected by HIV status, HCV co-infection, and alcohol use.
CDC: Disparities Account for Outsized HIV Infection Rate Among Black Women
May 17th 2019

CDC: Disparities Account for Outsized HIV Infection Rate Among Black Women

Wallace Stephens
Stubborn racial disparities mean that the rate of new HIV inections was 93% higher among black women than it would have been if the rate were the same as white women.
What We're Reading: Birth Rates Decline; Gilead CEO to Testify Over PrEP; Civica Rx Chooses First Products
May 16th 2019

What We're Reading: Birth Rates Decline; Gilead CEO to Testify Over PrEP; Civica Rx Chooses First Products

AJMC Staff
US birth rates have declined for the fourth year in a row; Gilead's chief executive officer (CEO) is expected to testify before a House committee about Truvada pricing; nonprofit generic drug company Civica Rx has chosen the first 2 antibiotics that it will produce.
Reactions Are Mixed as Gilead Announces PrEP Donations, Early Launch of Generic
May 11th 2019

Reactions Are Mixed as Gilead Announces PrEP Donations, Early Launch of Generic

Jaime Rosenberg
HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic version of the pill will come to market a year early. However, some activists are skeptic.
Survey Finds Pharmacy Students Have High Awareness of PrEP but Gaps Remain
May 8th 2019

Survey Finds Pharmacy Students Have High Awareness of PrEP but Gaps Remain

Jaime Rosenberg
Researchers from the University of Buffalo surveyed pharmacist students, finding high awareness of pre-exposure prophylaxis (PrEP) and generally positive attitudes towards it. However, the survey also revelaed gaps in knowledge, highlighting the need for more education.
PARTNER2 Study: Viral Suppression of HIV Prevents Sexual Transmission Between Gay Men
May 3rd 2019

PARTNER2 Study: Viral Suppression of HIV Prevents Sexual Transmission Between Gay Men

Wallace Stephens
Findings from PARTNER2 show that HIV-positive individuals who were virally suppressed by antiretroviral therapy had no risk of transmitting the virus by having sex without condoms.
Dr Stella Safo on How Changing Financial Models Might Create Management Challenges for HIV
May 1st 2019

Dr Stella Safo on How Changing Financial Models Might Create Management Challenges for HIV

As we move away from a system of external development grants that help us maintain our HIV models to a system where our returns on investment support the work that we do, there’s a concern that there will be some slimming down of services that get patients in to our practice, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
What We're Reading: Limited Screen Time for Children; HIV Prevention Drug Licensing; NYC Confirms 30 New Measles Cases
April 25th 2019

What We're Reading: Limited Screen Time for Children; HIV Prevention Drug Licensing; NYC Confirms 30 New Measles Cases

AJMC Staff
The World Health Organization recommends little to no screen time for children under age 5; senators urge HHS to ensure that government patents on the HIV prevention drug Truvada are properly licensed; New York City health officials have confirmed 31 new cases of measles in less than a week.
PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV
April 23rd 2019

PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV

Jaime Rosenberg
A new study has identified lower rates of sexual anxiety among gay and bisexual men taking pre-exposure prophylaxis (PrEP).
Antibody May Suppress HIV for Up to 4 Months in Patients Halting ART Regimens
April 22nd 2019

Antibody May Suppress HIV for Up to 4 Months in Patients Halting ART Regimens

Jaime Rosenberg
In a study of 29 virally suppressed patients who discontinued antiretroviral therapy (ART), every patient was able to maintain viral suppression from infusions of an antibody that blocks the HIV-binding site on CD4+ T cells.
In Small Amount of Patients, CD4+ T Cells Continue to Decline Despite Being Virally Suppressed
April 19th 2019

In Small Amount of Patients, CD4+ T Cells Continue to Decline Despite Being Virally Suppressed

Jaime Rosenberg
In rare cases, despite being on antiretroviral therapy and being virally suppressed, patients experience extreme immune decline.
Is Immunotherapy the Key to Developing an HIV Vaccine?
April 18th 2019

Is Immunotherapy the Key to Developing an HIV Vaccine?

Wallace Stephens
A new immunotherapy approach was found to both expose HIV concealed within CD4+ T cells and kill it, which could potentially lead to an eventual vaccine for the virus.
What We're Reading: Doctors Charged in Opioid Scheme; First US CRISPR Treatment; "Bubble Boy" Disease Cured
April 18th 2019

What We're Reading: Doctors Charged in Opioid Scheme; First US CRISPR Treatment; "Bubble Boy" Disease Cured

AJMC Staff
Dozens of doctors and other medical professionals have been charged with exchanging opioids and other drugs for sex and cash; the first 2 patients in the United States have been treated with CRISPR; doctors have cured infants of immunodeficiency syndrome using gene therapy made from HIV.
Depressive Symptoms May Increase the Risk of Death in Patients With HIV
April 13th 2019

Depressive Symptoms May Increase the Risk of Death in Patients With HIV

Wallace Stephens
Prevalence of depressive symptoms among individuals with HIV may lead to an increased risk of mortality.
What We're Reading: New Medicare for All Bill; Medicaid Work Requirement Appeal; PrEP Royalties
April 11th 2019

What We're Reading: New Medicare for All Bill; Medicaid Work Requirement Appeal; PrEP Royalties

AJMC Staff
Senator Bernie Sanders, I-Vermont, has reintroduced a Medicare for All bill while other Democrats eye an alternative; the Trump administration is appealing a federal judge's decision to toss out Medicaid work requirements in Kentucky and Arkansas; AIDS activists are pushing CDC to force Gilead to give the agency royalties for Truvada.
PrEP Initiation Associated With Increased STI Incidence Among Gay, Bisexual Men
April 11th 2019

PrEP Initiation Associated With Increased STI Incidence Among Gay, Bisexual Men

Jaime Rosenberg
A study of gay and bisexual men found that incidence of sexually transmitted infections (STIs) increased following pre-exposure prophylaxis (PrEP) initiation.
Can Couple-Based Interventions Prevent the Spread of HIV?
April 5th 2019

Can Couple-Based Interventions Prevent the Spread of HIV?

Wallace Stephens
Researchers evaluated differences in effectiveness of 2 couple-based preventive interventions aimed to reduce the spread of HIV and sexually transmitted infections among individuals in community supervision programs.
Weighing Management Strategies for HIV Medication Safety, Cost
April 4th 2019

Weighing Management Strategies for HIV Medication Safety, Cost

Jaime Rosenberg
While medical advances have improved lifespan and quality of life for patients with HIV, there are still opportunities for strategies that address both medication safety and costs.
Dr Ian Frank on the Convenience, Benefits of Single-Tablet Regimens for HIV
March 30th 2019

Dr Ian Frank on the Convenience, Benefits of Single-Tablet Regimens for HIV

People living with HIV who are taking single-tablet regimens have better medication adherence and lower hospitalizations than those taking multi-tablet regimens, explained Ian Frank, MD, professor of medicine, Perelman School of Medicine, University of Pennsylvania,
<1
...
181920212223242526
...
33>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo